EE04611B1 - Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina - Google Patents

Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina

Info

Publication number
EE04611B1
EE04611B1 EEP200100609A EEP200100609A EE04611B1 EE 04611 B1 EE04611 B1 EE 04611B1 EE P200100609 A EEP200100609 A EE P200100609A EE P200100609 A EEP200100609 A EE P200100609A EE 04611 B1 EE04611 B1 EE 04611B1
Authority
EE
Estonia
Prior art keywords
cinnamoylaminoalkyl
medicament
preparation
benzenesulfonamide derivative
substituted benzenesulfonamide
Prior art date
Application number
EEP200100609A
Other languages
English (en)
Estonian (et)
Inventor
Christian Englert Heinrich
Heitsch Holger
Wirth Klaus
G�Gelein Heinz
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200100609A publication Critical patent/EE200100609A/xx
Publication of EE04611B1 publication Critical patent/EE04611B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200100609A 1999-05-20 2000-05-06 Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina EE04611B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19923086A DE19923086A1 (de) 1999-05-20 1999-05-20 Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2000/004091 WO2000071513A1 (en) 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Publications (2)

Publication Number Publication Date
EE200100609A EE200100609A (et) 2003-02-17
EE04611B1 true EE04611B1 (et) 2006-04-17

Family

ID=7908577

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100609A EE04611B1 (et) 1999-05-20 2000-05-06 Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina

Country Status (30)

Country Link
US (1) US6350778B1 (xx)
EP (1) EP1183236B1 (xx)
JP (1) JP4559640B2 (xx)
KR (1) KR100968729B1 (xx)
CN (1) CN1243730C (xx)
AR (1) AR035625A1 (xx)
AT (1) ATE252554T1 (xx)
AU (1) AU771675B2 (xx)
BR (1) BR0010821B1 (xx)
CA (1) CA2374226C (xx)
CZ (1) CZ302943B6 (xx)
DE (2) DE19923086A1 (xx)
DK (1) DK1183236T3 (xx)
EE (1) EE04611B1 (xx)
ES (1) ES2208342T3 (xx)
HK (1) HK1047574B (xx)
HR (1) HRP20010845B1 (xx)
HU (1) HU229041B1 (xx)
IL (2) IL146372A0 (xx)
ME (1) MEP41508A (xx)
MX (1) MXPA01011725A (xx)
NO (1) NO321558B1 (xx)
PL (1) PL201560B1 (xx)
PT (1) PT1183236E (xx)
RS (1) RS50172B (xx)
RU (1) RU2242462C2 (xx)
SK (1) SK287237B6 (xx)
TR (1) TR200103312T2 (xx)
WO (1) WO2000071513A1 (xx)
ZA (1) ZA200109481B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054482A1 (de) * 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN1237185C (zh) * 2003-06-04 2006-01-18 中国科学院上海药物研究所 Sars冠状病毒3cl蛋白酶三维结构模型与抗sars药物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1518816C3 (de) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE1545810A1 (de) * 1965-05-06 1969-12-11 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
DK0612724T3 (da) 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE4341655A1 (de) 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
JPH0826995A (ja) * 1994-07-22 1996-01-30 Nisshin Flour Milling Co Ltd ベンズイミダゾール誘導体を含有する抗不整脈剤
DE19505397A1 (de) 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
ID28854A (id) 1998-09-10 2001-07-05 Aventis Pharma Gmbh Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptor
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors

Also Published As

Publication number Publication date
PL351751A1 (en) 2003-06-16
DK1183236T3 (da) 2004-02-23
EE200100609A (et) 2003-02-17
RS50172B (sr) 2009-05-06
KR100968729B1 (ko) 2010-07-08
CZ302943B6 (cs) 2012-01-25
CA2374226C (en) 2010-08-31
KR20020005046A (ko) 2002-01-16
PL201560B1 (pl) 2009-04-30
CZ20014149A3 (cs) 2002-03-13
AR035625A1 (es) 2004-06-23
YU81701A (sh) 2004-07-15
HUP0201906A2 (en) 2002-09-28
CN1243730C (zh) 2006-03-01
ZA200109481B (en) 2002-06-25
DE60006104T2 (de) 2004-08-05
JP2003500388A (ja) 2003-01-07
IL146372A (en) 2007-05-15
IL146372A0 (en) 2002-07-25
HRP20010845A2 (en) 2003-04-30
HRP20010845B1 (en) 2010-08-31
DE19923086A1 (de) 2000-11-23
MXPA01011725A (es) 2002-04-24
BR0010821B1 (pt) 2011-07-12
CA2374226A1 (en) 2000-11-30
EP1183236A1 (en) 2002-03-06
EP1183236B1 (en) 2003-10-22
BR0010821A (pt) 2002-03-05
WO2000071513A1 (en) 2000-11-30
SK16692001A3 (sk) 2002-04-04
ES2208342T3 (es) 2004-06-16
CN1360571A (zh) 2002-07-24
DE60006104D1 (de) 2003-11-27
HK1047574B (zh) 2006-08-04
ATE252554T1 (de) 2003-11-15
HUP0201906A3 (en) 2005-04-28
HK1047574A1 (en) 2003-02-28
PT1183236E (pt) 2004-03-31
AU5393300A (en) 2000-12-12
AU771675B2 (en) 2004-04-01
TR200103312T2 (tr) 2002-04-22
MEP41508A (en) 2011-02-10
NO20015636L (no) 2002-01-15
NO321558B1 (no) 2006-05-29
HU229041B1 (hu) 2013-07-29
US6350778B1 (en) 2002-02-26
RU2242462C2 (ru) 2004-12-20
NO20015636D0 (no) 2001-11-19
JP4559640B2 (ja) 2010-10-13
HRP20010845A9 (en) 2010-06-30
SK287237B6 (sk) 2010-04-07

Similar Documents

Publication Publication Date Title
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
ZA200110217B (en) Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application.
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
HUP0700086A2 (en) 2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
IL136425A0 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE200200399A (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
EE04855B1 (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
EE05168B1 (et) N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
HUP0201315A3 (en) 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
HUP0201797A3 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150506